174 related articles for article (PubMed ID: 18587559)
1. Evaluation of N (epsilon)-(3-formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy.
Zhang X; Lai Y; McCance DR; Uchida K; McDonald DM; Gardiner TA; Stitt AW; Curtis TM
Diabetologia; 2008 Sep; 51(9):1723-30. PubMed ID: 18587559
[TBL] [Abstract][Full Text] [Related]
2. Evidence supporting a role for N-(3-formyl-3,4-dehydropiperidino)lysine accumulation in Müller glia dysfunction and death in diabetic retinopathy.
Yong PH; Zong H; Medina RJ; Limb GA; Uchida K; Stitt AW; Curtis TM
Mol Vis; 2010 Dec; 16():2524-38. PubMed ID: 21151599
[TBL] [Abstract][Full Text] [Related]
3. Müller glial dysfunction during diabetic retinopathy in rats is reduced by the acrolein-scavenging drug, 2-hydrazino-4,6-dimethylpyrimidine.
McDowell RE; Barabas P; Augustine J; Chevallier O; McCarron P; Chen M; McGeown JG; Curtis TM
Diabetologia; 2018 Dec; 61(12):2654-2667. PubMed ID: 30112688
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema.
Boehm BO; Schilling S; Rosinger S; Lang GE; Lang GK; Kientsch-Engel R; Stahl P
Diabetologia; 2004 Aug; 47(8):1376-9. PubMed ID: 15258735
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of N(ε)- Carboxy methyl lysine (N(ε)-CML) are associated with topographic alterations in retinal pigment epithelium: A preliminary study.
Mishra N; Saxena S; Ruia S; Prasad S; Singh V; Khanna V; Staffa R; Gaspar L; Kruzliak P
J Diabetes Complications; 2016 Jul; 30(5):868-72. PubMed ID: 27039312
[TBL] [Abstract][Full Text] [Related]
6. Localization of Acrolein-Lysine Adduct in Fibrovascular Tissues of Proliferative Diabetic Retinopathy.
Dong Y; Noda K; Murata M; Yoshida S; Saito W; Kanda A; Ishida S
Curr Eye Res; 2017 Jan; 42(1):111-117. PubMed ID: 27249374
[TBL] [Abstract][Full Text] [Related]
7. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
Ghanem AA; Elewa A; Arafa LF
Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
[TBL] [Abstract][Full Text] [Related]
8. Association of serum N(ε)-Carboxy methyl lysine with severity of diabetic retinopathy.
Mishra N; Saxena S; Shukla RK; Singh V; Meyer CH; Kruzliak P; Khanna VK
J Diabetes Complications; 2016 Apr; 30(3):511-7. PubMed ID: 26782022
[TBL] [Abstract][Full Text] [Related]
9. Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.
Choudhuri S; Dutta D; Sen A; Chowdhury IH; Mitra B; Mondal LK; Saha A; Bhadhuri G; Bhattacharya B
Mol Vis; 2013; 19():100-13. PubMed ID: 23378723
[TBL] [Abstract][Full Text] [Related]
10. Soluble Vascular Adhesion Protein-1 Mediates Spermine Oxidation as Semicarbazide-Sensitive Amine Oxidase: Possible Role in Proliferative Diabetic Retinopathy.
Murata M; Noda K; Kawasaki A; Yoshida S; Dong Y; Saito M; Dong Z; Ando R; Mori S; Saito W; Kanda A; Ishida S
Curr Eye Res; 2017 Dec; 42(12):1674-1683. PubMed ID: 28937866
[TBL] [Abstract][Full Text] [Related]
11. Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients.
Kerkeni M; Saïdi A; Bouzidi H; Letaief A; Ben Yahia S; Hammami M
Diab Vasc Dis Res; 2013 May; 10(3):239-45. PubMed ID: 23091285
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes.
Suguro T; Watanabe T; Kodate S; Xu G; Hirano T; Adachi M; Miyazaki A
Clin Sci (Lond); 2008 Dec; 115(11):327-34. PubMed ID: 18338983
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
[TBL] [Abstract][Full Text] [Related]
14. Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
Hirata K; Kubo K
Endocr J; 2004 Dec; 51(6):537-44. PubMed ID: 15644571
[TBL] [Abstract][Full Text] [Related]
15. The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy.
Ozmen B; Boyvada S
J Diabetes Complications; 2003; 17(3):128-34. PubMed ID: 12738396
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum levels of AGEs, sRAGE, and pentosidine in Tunisian patients with severity of diabetic retinopathy.
Kerkeni M; Saïdi A; Bouzidi H; Ben Yahya S; Hammami M
Microvasc Res; 2012 Nov; 84(3):378-83. PubMed ID: 22835520
[TBL] [Abstract][Full Text] [Related]
17. Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.
Hamada Y; Nakamura J; Naruse K; Komori T; Kato K; Kasuya Y; Nagai R; Horiuchi S; Hotta N
Diabetes Care; 2000 Oct; 23(10):1539-44. PubMed ID: 11023149
[TBL] [Abstract][Full Text] [Related]
18. Pentosidine - a new biochemical marker in diabetic retinopathy.
Salman AG; Mansour DE; Swelem AH; Al-Zawahary WM; Radwan AA
Ophthalmic Res; 2009; 42(2):96-8. PubMed ID: 19546600
[TBL] [Abstract][Full Text] [Related]
19. Association of serum and vitreous concentrations of osteoprotegerin with diabetic retinopathy.
Yu G; Ji X; Jin J; Bu S
Ann Clin Biochem; 2015 Mar; 52(Pt 2):232-6. PubMed ID: 24723620
[TBL] [Abstract][Full Text] [Related]
20. Association of increased levels of MCP-1 and cathepsin-D in young onset type 2 diabetes patients (T2DM-Y) with severity of diabetic retinopathy.
Reddy S; Amutha A; Rajalakshmi R; Bhaskaran R; Monickaraj F; Rangasamy S; Anjana RM; Abhijit S; Gokulakrishnan K; Das A; Mohan V; Balasubramanyam M
J Diabetes Complications; 2017 May; 31(5):804-809. PubMed ID: 28336215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
